MGShell
The company develops a magnesium-based drug delivery platform specifically designed for the treatment of retinal diseases. This technology aims to improve patient adherence to ophthalmological treatments and reduce overall healthcare costs. The platform serves as a specialized medical device for delivering medication directly to the eye.
Visit websitePieve Emanuele, Italy
Healthtech
MedTech
Ophthalmology
Biotechnology
Funding summary
- Total raised
- €1.1M
- Funding rounds
- 1
Investors in MGShell
Investors on record for MGShell. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like MGShell?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors